NEW YORK, June 22, 2023 (Newswire.com) - iQuanti: Urgent care is for injuries and illnesses requiring prompt medical attention but not severe enough to go to the emergency room. If you need treatment within 24 or 48 hours but can't get an appointment to see your primary care physician (or you don't have a primary care physician), you can visit urgent care. 

If you are experiencing more serious symptoms requiring lifesaving medical attention, such as chest pain, a head injury or uncontrolled bleeding, call 9-1-1 or go to the emergency department as soon as possible.¹ An urgent care center is not an emergency department.  

What services and treatments can I get at urgent care? 

The services and treatments available at urgent care centers vary but often include the following: 

• Allergies 
• COVID-19 testing 
• Illness 
• Injuries 
• Physicals 
• Occupational Medicine 
• Telehealth 
• X-rays and Diagnosis  

Common, non-life-threatening illnesses and injuries treated at urgent care clinics include:  

• Colds and flu 
• Allergic reactions 
• Bug bites and rashes 
• Eye irritation 
• Sore throat  
• Diarrhea and gastrointestinal issues 
• Urinary tract infections (UTIs) 
• Vomiting 
• Sprains and strains 
• Infections 
• Cuts, burns, and lacerations  

Where can you access urgent care? 

As a result of the increase in demand for tests and treatment during the COVID-19 pandemic, the number of urgent care centers has grown.  

According to data from the Urgent Care Association, there are over 11,000 urgent care centers around the United States today, and this number is growing by 7% per year. Since 2019, patient volume at urgent care centers has increased by 60%.²  

A shortage of primary care physicians, the high costs of emergency room visits, and convenience are some of the reasons people are increasingly using urgent care centers. 

Urgent care centers are available all over the U.S. for in-person appointments, and many facilities also offer online visits. This makes it possible to see a medical provider without leaving your home. While urgent care clinic hours vary, many are open seven days a week with extended daytime hours. Some urgent care clinics also offer 24-hour care.  

How to find an urgent care center 

The easiest way to find an urgent care center near you is to enter "urgent care near me" in your maps app.  

Alternatively, you can search online for "urgent care" in your area. If you know which urgent care company you want to visit, you can also search for a location near you on the urgent care company's website.    

Common services provided by urgent care centers include in-person and virtual care for ear infections, cold and flu symptoms, physical examinations, and more. 

References:  

¹Mayo Clinic. Emergency vs. urgent care: What's the difference? Accessed Feb. 25, 2023.  

²CNN. Why urgent care centers are popping up everywhere. Accessed Feb. 26, 2023.  

CHICAGO, June 22, 2023 (Newswire.com) - First Stop Health ("FSH"), a direct, virtual healthcare provider, announced today a strategic investment made by Sverica Capital Management LP ("Sverica").  

Headquartered in Boston, Massachusetts, Sverica is a leading growth-oriented private equity investment firm with deep healthcare expertise. Now on its sixth fund, Sverica is poised to help FSH further establish itself as the premier employer virtual healthcare provider. For the last 20+ years, Sverica has been collaborating with management teams to help them scale their businesses with a focus on ambitious strategy, developing talent, and building world-class infrastructure and processes.   

"We are thrilled to work with Sverica, who embraces our commitment to our patients and understands how to leverage our strengths to accelerate our growth and maximize our impact. The work of bringing care that people love® to reality is ambitious and energizing," says Teira Gunlock, CEO of First Stop Health. Gunlock will continue to lead the company while Gregg Osenkowski, Partner at Sverica, and Doug Patrican, Vice President at Sverica, will join the FSH Board of Directors.  

"We are excited to partner with the First Stop Health team and to advance their mission to provide employers and employees with the highest-quality virtual health services," said Osenkowski. Patrican added, "First Stop Health's focus on delivering exceptional patient care permeates the entire organization and we look forward to supporting the FSH team as they continue to execute on their vision and growth plans."  

FSH was co-founded by Patrick Spain and Dr. Mark Friedman. "'Mark and I founded FSH to help fix a reimbursement-based healthcare system that was not working for patients or the employers who pay the bills for a system bloated with 'paperwork' — we believe that we have made headway in achieving this goal," said Spain. Dr. Friedman added, "First Stop Health is working to address many of the problems with healthcare today. We are proud to be part of the solution." 

Ernst & Young Capital Advisors, LLC served as the exclusive financial advisor to First Stop Health on the transaction. 

About Sverica Capital Management 

Sverica Capital Management is a leading growth-oriented private equity firm that has raised $2 billion across six funds. The firm acquires, invests in and actively builds companies that are, or could become, leaders in their industries. Since inception, Sverica has followed a "business builder" approach to investing and takes an active supporting role in its portfolio companies. Sverica devotes significant internal time and resources to help its management teams develop and execute growth strategies and proactively looks for levers to pull to accelerate growth by reinvesting back into those companies. Sverica firmly believes in building businesses collaboratively that can endure for the long term by starting with a durable foundation and bringing the right people and playbook to drive reinvestment and, ultimately, strong returns for its investors. For more information, please visit https://sverica.com. 

About First Stop Health 

First Stop Health (FSH) provides care that people love® with various digital healthcare services. Patients can access virtual care 24/7 via app, website or phone. FSH helps patients save time and money with safe, convenient, high-quality virtual care solutions —  Primary Care, Urgent Care and Mental Health. FSH was named one of Inc. Magazine's Best Workplaces of 2022 and 2023 and ranked one of the fastest-growing private companies for the past five years by Inc. 5000. For more information, please visit www.fshealth.com. 

ATLANTA, June 22, 2023 (Newswire.com) - Today, SENTA ("Southern Ear, Nose, Throat and Allergy Physicians") proudly announces that South Carolina ENT, Allergy & Sleep Medicine ("SCENT") is expanding to include a new 21,000-sq.-ft. flagship building, housing a 14-exam room clinic, a six-days-a-week walk-in clinic, and a state-of-the-art ambulatory surgical center (ASC). This innovative, patient-centered facility will specialize in providing high-quality, compassionate care in an outpatient and ambulatory setting. SENTA Partners is backed by Shore Capital Partners and is committed to partnering with leading physicians to build a premier network of ENT and allergy services in the U.S.

"SCENT Surgical Center will be the only surgical center in Columbia exclusively specializing in ENT surgical procedures. This center will enable us to provide the very latest in quality care to our patients throughout South Carolina," said Robert Puchalski, M.D., medical director. "SENTA's unparalleled support and expertise have allowed us to accelerate our growth in the marketplace; I can't wait to see the positive impact this new offering will have on physician recruitment, the efficiency of care, savings for our commercially-insured patients, and most importantly, the overall health of our local community." 

SCENT Ambulatory Surgical Center in South Carolina has a highly trained professional staff committed to providing patients with the best care and treatments possible. It is the second-largest privately-owned ENT and Allergy practice in the state. The surgeons at SCENT Surgical Center are board-certified and specialize in a wide spectrum of ENT surgical procedures. SCENT physicians also partner with the University of South Carolina School of Medicine, providing elective rotations for residents and medical students. SCENT physicians also take a leading role in the medical community by partnering with MUSC and PRISMA to provide consultative on-call services for inpatients and emergency department patients.

"Partnering with our practices to understand and identify what's needed in their community is key to success both to accelerate our treatment capabilities and grow the business," said Adam Low, CEO, SENTA. "Identifying best practices and scaling them, such as the addition of the ASC in the South Carolina market, along with exceptional quality patient care, is a cornerstone for SENTA and this further delivers on our mission." 

If interested in learning more about a partnership with SENTA, contact the Chief Development Officer, Zack Usilton, at [email protected] 

ABOUT SENTA PARTNERS

Southern Ear, Nose, Throat and Allergy Physicians (SENTA) is a leading community of the finest ENT and Allergy/Immunology specialists in the Southern region. SENTA provides the highest quality allergy, asthma, immunology, and otolaryngology care leading to better patient outcomes. Founded in 2019 with an investment from Shore Capital Partners, SENTA provides strategic, operational, and administrative support to our ENT partner practices and allergy, empowering physicians to focus on their patients. For additional information on SENTA, please visit www.SENTAPARTNERS.com. 

Intend Logo
Intend, Inc. Logo

FULLERTON, Calif., June 22, 2023 (Newswire.com) - Intend, Inc., a patient-centric healthcare management software provider, today announced a strategic partnership with Mobility Health, a Mason, Ohio-based biohealth diagnostic company that pushes the boundaries of innovation in molecular science to provide accurate, rapid testing of infectious diseases to pharmacies nationwide. This landmark partnership provides pharmacies and other medical service providers with a Mobility Health branded version of the Intend Platform featuring real-time integration with laboratory testing and medical billing services.

Under this Value-Added Reseller (VAR) partnership, Mobility Health will offer a custom-branded version of the Intend Platform to their over 200 independent pharmacy clients and potentially thousands of pharmacies nationwide.

This powerful platform, strengthened by Mobility Health's expert diagnostic testing, will provide pharmacies and other medical service providers with comprehensive, seamless solutions designed to streamline medical service delivery processes from marketing to medical billing and everything in between.

"Intend, Inc. has always aimed to create technology that transforms and streamlines healthcare delivery," said Eric Kupferberg, President of Intend, Inc. "This partnership with Mobility Health will further extend the capabilities of our platform, opening new avenues of service delivery and leading to significant improvements in the medical care provided by pharmacies and medical providers nationwide."

Sandra Gunselman, Ph.D., Founder, President & CEO of Mobility Health, shared, "We're delighted to enter the partnership with Intend offering us an opportunity to leverage their industry-leading platform to provide the pharmacy a complete end-to-end provider services solution. Intend allows us to extend the capabilities of our laboratory and billing service offering to existing and new pharmacy clients, all while extending our mission of decentralizing lab services and enabling wider, more equitable access to diagnostics that can improve lives."

About Mobility Health

Mobility Health is a biohealth diagnostic company focused on providing accurate, rapid testing of infectious diseases to protect population health and safety. Mobility Health was established with a mission to transform community-based healthcare by deploying new technologies that eliminate barriers to rapid, advanced molecular testing and healthcare services. Founded in 2020 by Sandra Gunselman, Ph.D., a molecular biologist, and laboratory operations expert with a passion for reaching patients in need, the company is an integral member of the Mason Tech Elevator, which serves as a living lab for corporate collaboration, mentoring, and entrepreneurship to spur novel bioscience and technology innovations. For more information, visit http://www.mobilityhealthlab.com.

About Intend

Intend delivers marketing campaign management, medical service scheduling, insurance verification, ePrescriptions, billing, reporting, and patient communication to healthcare providers nationwide. Since 2020, the Intend software platform has processed over 5.5 million medical procedures across more than 5,000 client accounts, serving millions of patients. The company's customizable SaaS solutions focus on:

• Marketing campaign automation via email, text and internet advertising
• Online appointment scheduling with patient and client account portals
• Automated insurance verification and medical billing integration
• ePrescription writing and integration with the SureScripts Network
• Flexible integrations with laboratories and state government agencies

Intend partners with pharmacies, urgent care providers, physician offices, and laboratories to enhance business function while delivering superior patient care.

For more information or to schedule a demo, visit https://demo.intend.io.

Doctor Denker

BOCA RATON, Fla., June 22, 2023 (Newswire.com) - Dr. Mark Denker, a renowned board-certified obstetrician/gynecologist who founded the Palm Beach Fertility Center, has been selected to present at the 8th International Conference on Reproductive Health, Embryology and Fertility, taking place July 10-11, 2023, in Dubai, UAE. Dr. Denker's presentation will focus on his clinical trial that proves an estrogen androgen priming protocol dramatically improves response to gonadotropins in IVF cycles.

The reproductive health conference featuring Dr. Denker serves as a global platform for world-leading gynecologists and other healthcare professionals to exchange knowledge on reproductive health and educate one another about cutting-edge research studies and findings. The two-day event features discussions, keynote presentations, poster presentations, exhibitions, symposiums, workshops and a young researcher's forum.

Dr. Denker's session will detail his years of optimizing IVF protocols for older women and poor responders. His research leveraged earlier findings that priming the ovaries with estrogen prior to an IVF cycle is highly beneficial, as well as androgen priming. His study questioned if treatment would be more effective if the two hormones were combined, which led to his clinical trial with poor responder patients who had been canceled in a previous IVF cycle or had done poorly. They were treated with an estrogen and androgen priming protocol, which resulted in a 40 percent pregnancy rate in trial participants.

Dr. Denker has garnered international attention for his best-in-class care offered at the Palm Beach Fertility Center, which he founded to offer personalized and affordable reproductive healthcare. Due to his efforts, more than 5,000 babies have been born through effective fertility treatments—many of whom were born to women with a history of failed treatments or older women with decreased ovarian reserve. Dr. Denker earned his medical degree from Baylor College of Medicine in Houston, Texas, after which he completed his residency in Obstetrics and Gynecology at the University of Miami/Jackson Memorial Hospital. In addition, he completed a fellowship in Reproductive Endocrinology at the University of California Irvine. He is the recipient of the Pacific Coast Fertility Society prize paper, University of California Research Symposium Award, and a President's Undergraduate Research Fellowship.

To learn more about the 8th International Conference on Reproductive Health, Embryology and Fertility, visit https://reproductivehealth.conferenceseries.com.

Additional information about Dr. Denker's fertility practice is available online at https://www.palmbeachfertility.com.

iLet Dexcom G6
iLet with Dexcom G6

• Now the iLet Bionic Pancreas is cleared for three insulins
• More insulin choices for users
• Prefilled insulin cartridge saves time and provides convenience for users

CONCORD, Mass., June 22, 2023 (Newswire.com) - Beta Bionics, Inc. — a medical technology company focused on diabetes — announces FDA 510(k) clearance for compatibility with the Fiasp^® Pumpcart^® (insulin aspart) prefilled insulin cartridge. The iLet is the first and only automated insulin-delivery system that does not require carb counting, fully automates 100% of all user insulin doses, and will provide users the choice of three insulins - Novolog^®, Humalog^® and Fiasp^® Pumpcart^®. 

"Beta Bionics has been working tirelessly to create an insulin delivery system that offers less burden and more convenience for the type 1 community. Since launching last month in May 2023, the iLet Bionic Pancreas is now available and clinics and users are being trained on its simple design and easy management features," said Sean Saint, President and CEO of Beta Bionics. "When Fiasp^® Pumpcart^® prefilled cartridges are available, users will save time not having to manually fill cartridges and will have more choice for their diabetes management."

The iLet was designed to alleviate the work of diabetes management in everyday life and nearly eliminate the expertise that has been required to set up and manage a traditional insulin pump. The only input that is required to get started is the user's weight. No carb counting^*, bolusing, correction factors, insulin-to-carb ratios, or pre-set basal rates - the iLet manages a user's glucose levels with just a meal announcement and it does the rest of the work. The iLet is paired with a Dexcom G6 Continuous Glucose Monitoring System for glucose readings.

If you'd like to GO BIONIC with the iLet Bionic Pancreas, visit our website to fill out a form to get started - www.betabionics.com. 

*Carb awareness is required. 

Fiasp^® Pumpcart^®, Humalog^® and Novolog^® are registered trademarks of Novo Nordisk A/S. Fiasp^® Pumpcart^® not yet available for sale in the US.